- ABOUT ME
- AREAS OF FOCUS
- EDUCATION & LEADERSHIP
- LOCATIONS & HOSPITALS
- NEWS & PUBLICATIONS
I am deeply committed to giving my best for all my patients with cancer. It has been very fulfilling for me to use my skills and training to provide compassionate care for my patients.
Dr. Alice Wang-Chesebro is deeply committed to providing compassionate, individualized care for patients with cancer. During medical school, she developed a close connection with many of her patients and their families, inspiring her decision to pursue a career in oncology. She believes cancer treatment is most successful when patients feel informed, supported, and actively involved in decisions about their care.
Dr. Wang-Chesebro completed her undergraduate studies at Harvard University before earning her medical degree from Johns Hopkins University School of Medicine. She received the National Cancer Institute’s Cancer Research Training Award and spent a year studying protein expression in squamous cell cancer. Following internship training at Legacy Emanuel Hospital, she completed her residency in radiation oncology at the University of California, San Francisco, where she served as Chief Resident.
Today, Dr. Wang-Chesebro specializes in treating breast, gastrointestinal, gynecologic, and lung cancers as well as other cancers and benign tumors. As Medical Director of the Clackamas Radiation Oncology Center, she combines evidence-based treatment with a personalized approach, helping patients understand their options and develop care plans tailored to their goals and circumstances.
Outside of medicine, Dr. Wang-Chesebro enjoys traveling, reading, music, and discovering new foods. She especially values spending time with her husband and three children and exploring new adventures together.
Other Activities
Member, American Society for Radiation Oncology (ASTRO), 2004-Present
Member, Oregon Medical Association, 2008-Present
Referee, International Journal of Radiation Oncology Biology Physics, 2005-2012
Areas of Focus
Breast Cancer
Gastrointestinal Cancer
Gynecologic Cancer
Lung Cancer
Skin Cancer
Head & Neck Cancer
Image-Guided Intensity-Modulated Radiotherapy (IGRT/IMRT)
Volumetric Modulated Arc Radiotherapy (VMAT)
Stereotactic Radiosurgery using Gamma Knife & Linear Accelerator
Stereotactic Ablative Body Radiotherapy (SBRT/SABR)
3D Conformal Radiotherapy
Electron Beam Radiotherapy
EDUCATION & TRAINING
Chief Resident, University of California, San Francisco, 2008
Residency, Internal Medicine, University of California, San Francisco, 2008
Internship, Internal Medicine, Legacy Emanuel Hospital, 2004
MD, Johns Hopkins University School of Medicine, 2003
BA, Harvard University, 1998
BOARD CERTIFICATION
Radiation Oncology
LEADERSHIP
Medical Director, Clackamas Radiation Oncology Center, 2015-Present
Physician Member, Providence Regional Breast Program Steering Committee, 2014-Present
Physician Member, Providence Cancer Institute Protocol Selection Committee, 2014-Present
MD Quality Peer Review Officer for Radiation Oncology, Providence Health System Quality Assurance, 2014-2024
MD Reviewer, Institutional Review Board, Providence Health and Services, 2008-2010
Scientific Advisory Board Member, Consano, 2013-2020
HONORS
Portland Monthly Magazine Top Doctor, Radiation Oncology, 2017-2026
Fellow, UCSF School of Medicine Resident Teaching Fellowship, 2005
Cancer Research Training Award, National Cancer Institute, Bethesda, MD, 2002
Dean’s Award for Research, Johns Hopkins School of Medicine, 1999
Locations
Hospitals Served
- Providence Portland Medical Center
- Providence St. Vincent Medical Center
- Providence Milwaukie Hospital
- Providence Willamette Falls Medical Center
Publications
Wang-Chesebro A, Pouliot J, Lessard E, Roach M III, Hsu IC. Can inverse planning further reduce dose to urethra for prostate high dose rate brachytherapy boost? ASTRO 48th Annual Meeting. November 5-9, 2006.
Xia P, Ludlum E, Mu G, Wang-Chesebro A, Coleman J, Akazawa C, Verhey L, Roach M III. Adaptive strategy for pelvic nodal irradiation in the treatment of prostate cancer. UCSF Radiation Oncology IGART Course. San Francisco, CA. May 18, 2006.
IMRT Improves Pelvic Lymph Node Coverage and Dose to Critical Structures Compared with Standard Four Field Whole Pelvis Radiation Therapy in Prostate Cancer. ASTRO 47th Annual Meeting. Denver, CO. 2005. Int J Radiat Oncol Biol Phys. 63(2, S1):S194. Oral poster discussion.
Aubin M, Morin O, Wang A, Bani-Hashemi A, Bucci K, Chen J, Ghelmansaraf F, Gillis A, Verhey L, Roach M III, Pouliot J. Megavoltage conebeam CT to complement prostate planning CT in presence of hip prosthesis. 8th Biennial ESTRO Meeting on Physics and Radiation Technology for Clinical Radiotherapy. Abstract 277, S129, 2005.
Cataisson C, Wang A, Subleski J, Joseloff E, Vinson C, Wiltrout R, Yuspa S. AP-1 mediates apoptosis and epidermal inflammation in protein kinase C alpha transgenic keratinocytes. Society for Investigative Dermatology 63rd Annual Meeting. May 15-18, 2002.
Research
Clinical trials: Member, Alliance for Clinical Trials in Oncology
Co-investigator on industry-sponsored trials
news
BLOG